Saroglitazar 4 Mg in Metabolic Dysfunction‐Associated Steatotic Liver Disease: 24‐Week Results From Phase 4 Study

20260 citationsJournal Article

Authors

CTRI/2023/05/053326 [Registered on: 31/05/2023].

Good health and well-being

Published in: Liver International

Volume 46, Issue 4, pp. e70558-e70558

Field-Weighted Citation Impact: 0.00